SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

BURMEISTER, Jayme E.; PEREIRA, Rafael R.; HARTKE, Elisa M.  and  KREUZ, Michele. Topiramate and severe metabolic acidosis: case report. Arq. Neuro-Psiquiatr. [online]. 2005, vol.63, n.2b, pp. 532-534. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X2005000300032.

    1. Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 2004;6:57-75. [ Links ]

    2. Chandramouli J. Newer anticonvulsant drugs in neuropathic pain and bipolar disorder. J Pain Palliat Care Pharmacother 2002;16:19-37. [ Links ]

    3. Brandes JL, Saper JR, Diamond M, et al. and MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;25:965-973. [ Links ]

    4. Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61:490-495. [ Links ]

    5. Krymchantowski AV, Tavares C, Penteado JC, et al. Topiramato no tratamento preventivo da migrânea: experiência em um centro terciário. Arq Neuropsiquiatr 2004;62:91-95. [ Links ]

    6. Ozer Y, Altunkaya H. Topiramate induced metabolic acidosis. Anaesthesia 2004;59:830. [ Links ]

    7. Tartara A, Sartori I, Manni R, Galimberti CA, Di Fazio M, Perucca E. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial. Ital J Neurol Sci 1996;17:429-432. [ Links ]

    8. Fakhoury T, Murray L, Seger D, McLean M, Abou-Khalil B. Topiramate overdose: clinical and laboratory features. Epilepsy Behav 2002;3:185-189. [ Links ]

    9. Takeoka M, Riviello JJ Jr, Pfeifer H, Thiele EA. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia 2002;43:1072-1075. [ Links ]

    10. Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 2002;43:744-747. [ Links ]

    11. Levisohn PM. Safety and tolerability of topiramate in children. J Child Neurol 2000;15(Suppl 1):22-26. [ Links ]

    12. Montenegro MA, Guerreiro MM, Scotoni AE, Guerreiro CA. Predisposition to metabolic acidosis induced by topiramate. Arq Neuropsiquiatr 2000;58:1021-1024. [ Links ]

    13. Stowe CD, Bollinger T, James LP, Haley TM, Griebel ML, Farrar HC 3rd. Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy. Pharmacotherapy 2000;20:105-109. [ Links ]

    14. Wilner A, Raymond K, Pollard R. Topiramate and metabolic acidosis. Epilepsia 1999;40:792-795. [ Links ]

    15. Ko CH, Kong CK. Topiramate-induced metabolic acidosis: report of two cases. Dev Med Child Neurol 2001;43:701-704. [ Links ]

    16. Izzedine H, Launay-Vacher V, Deray G. Topiramate-induced renal tubular acidosis. Am J Med 2004;116:281-282. [ Links ]

    17. Takeoka M, Holmes GL, Thiele E, et al. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 2001;42:387-392. [ Links ]

    19. Rose BD. Etiology and diagnosis of type 1 and type 2 renal tubular acidosis. In In Rose BD (ed). Up to date, Wellesley: UpTo Date, 2004. [ Links ]

    20. Post TW, Rose BD. Approach to the adult with metabolic acidosis. In Rose BD (ed). Up to date, Wellesley: Up To Date, 2004. [ Links ]

    21. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41(Suppl 1):35-39. [ Links ]

    22. Wiederkehr M, Krapf R. Metabolic and endocrine effects of metabolic acidosis in humans. Swiss Med Wkly 2001;131:127-132. [ Links ]